RowAnalytics secures seed funding led by Astia Angels and Wheatsheaf Group to accelerate international expansion.
Astia Angels and Wheatsheaf Group have backed the genomic analytics firm in its latest funding round.
RowAnalytics employs patented artificial intelligence analytics to interpret complex genomics and lifestyle data, providing insights into healthcare and agriculture.
RowAnalytics has secured a seed investment round led by Astia Angels, with participation from Wheatsheaf Group. The company intends to direct the capital towards accelerating its product launch schedule and expanding into new international markets.
The firm utilises its precisionlife artificial intelligence platform to decode complex genomic data, aiming to improve healthcare outcomes and agricultural practices. Alongside the funding announcement, RowAnalytics has relocated to larger premises in Kidlington to accommodate its anticipated workforce expansion.
From the founder
"We have developed innovative analytics and AI capabilities that enable a new generation of precision medicine and precision agriculture solutions. The ability to deliver combinatorial, multi-omic analysis at scale is a critical missing piece in realising the benefits of the genomics, IOT and AI revolutions. This investment will enable us to scale our business to address the significant global opportunities in these high-growth markets."
Steve Gardner
CEO at RowAnalytics
Investor perspective
"We are excited to be investing in a hugely experienced leadership team creating new value from complex life science data. Astia Angels member investors around the globe are participating in this deal: from Silicon Valley, New York and Boston to London and Frankfurt, reflecting the truly global nature of our network and our ability to identify high growth potential companies with women in positions of equity and influence. The potential for RowAnalytics is extremely exciting and there was real enthusiasm for this investment and team from our members."
Sharon Vosmek
CEO, Astia Angels
Use of funds
- 01Continue product development
- 02Expand into international markets
Investors
Categories
About the company
RowAnalytics
RowAnalytics develops artificial intelligence tools to interpret complex genomics and multi-omic data.